A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

In recognition of American Heart Month this February, MyMichigan will dedicate its Monday column to a series of educational articles about heart health. This week features heart failure. The Centers ...

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

Click on the status to view our full coverage. Lonapegsomatropin-tcgd (Ascendis Pharma) Long-acting growth hormone Treatment of adults with growth hormone deficiency. Supplemental BLA accepted for ...

Heart failure (HF ... to the outpatient management of acute and chronic decompensated HF. The use of outpatient IV nesiritide was considered a promising treatment option for symptomatic chronic ...

ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) have become an essential treatment for heart disease, particularly in managing conditions like heart failure and high blood pressure.

Hence, HDD and levosimendan may be optimal agents in the treatment of AHF with renal dysfunction ... MeSH terms included keywords, including “acute heart failure”, “acute decompensated heart failure”, ...